-+ 0.00%
-+ 0.00%
-+ 0.00%

ELEVANCE EXEC SAYS IT CONTINUE TO VIEW 2% TO 4% AS THE APPROPRIATE MEDICAID MARGIN TARGET

Reuters·10/21/2026 12:36:55

Please log in to view news